Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Respiratory Syncytial Virus Infections × Ribavirin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hepatitis C 4 Carcinoma, Hepatocellular 3 Respiratory Tract Infections 2 Respiratory Syncytial Virus Infections 1 Recurrence 1 Pneumonia 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Non-Hodgkin 1 Liver Neoplasms 1 Liver Diseases 1 Leukemia, Myeloid, Acute 1 Infections 1 Hepatitis 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Carcinoma, Squamous Cell 1 Bronchiolitis Obliterans Syndrome 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01502072 2021-02-15

Respiratory Syncytial Virus - RSV Protocol

M.D. Anderson Cancer Center

Phase 2 Completed

48 enrolled 11 charts

Neoplasms, Pneumonia, Respiratory Tract Infections, Respiratory Syncytial Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡